ClinicalTrials.Veeva

Menu

Effects of Coffee Consumption on Glucose Metabolism

U

University of Brasilia

Status

Completed

Conditions

Healthy

Treatments

Other: Water without Sugar
Other: Decaffeinated Coffee without Sugar
Other: Water with Sugar
Other: Coffee without Sugar
Other: Coffee with Sugar

Study type

Interventional

Funder types

Other

Identifiers

NCT02099929
GliCafé

Details and patient eligibility

About

Epidemiological studies have shown an inverse association between coffee consumption and risk of type 2 diabetes mellitus (T2DM). However the experimental studies that analysed the mechanisms are limited.

This project aims to assess the effects of coffee consumption on glucose metabolism, using stable isotope tracer (13C-glucose) to explain the possible metabolic mechanisms involved on the reduced risk for T2DM.

Full description

This is a crossover randomized clinical trial that has been studying 14 male healthy young adults, who were enrolled five treatments: coffee with sugar, coffee without sugar, decaffeinated coffee without sugar and two controls (water with and without sugar).

The stable isotope minimal model protocol with oral glucose administration (Oral Dose Intravenous Label Experiment - ODILE) was performed. The use of ODILE methodology permits separation of the glucose absorbed and removed from the circulation increasing the accuracy and the effectiveness of glucose uptake and insulin sensitivity (Bluck et al., 2006).

Enrollment

14 patients

Sex

Male

Ages

18 to 50 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Male healthy young adults (18 - 50 years old);
  • Body mass index (BMI) between 18.5 - 28.0 kg/m²;
  • No weight changes (≥ 5 kg) in the last 3 months;
  • Not take any pills/drugs that alter metabolism, appetite and sleep;
  • Not have sleep disorders;
  • Not have donated blood in the last 3 months;
  • Regular breakfast consumption (≥100 kcal ingested up to 2 hours after waking ≥4x/week);
  • Being a habitual coffee consumer (≥100mL ≥5x/week).

Exclusion criteria

  • Diagnosis of anemia, metabolic and heart diseases;
  • Previous sudden fainting and convulsions;
  • Any drugs and tobacco consumption;
  • Consumption of more than 500mg of caffeine / day (5 cups of coffee, tea and cola soft drinks).

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Single Blind

14 participants in 5 patient groups

Coffee with Sugar
Experimental group
Description:
300mL of Coffee with 30g of Sugar
Treatment:
Other: Coffee with Sugar
Coffee without Sugar
Experimental group
Description:
300mL of Coffee without Sugar
Treatment:
Other: Coffee without Sugar
Decaffeinated Coffee without Sugar
Experimental group
Description:
300mL of Decaffeinated Coffee without Sugar
Treatment:
Other: Decaffeinated Coffee without Sugar
Water with Sugar
Sham Comparator group
Description:
300mL of Water with 30g of Sugar
Treatment:
Other: Water with Sugar
Water without Sugar
Sham Comparator group
Description:
300mL of Water without Sugar
Treatment:
Other: Water without Sugar

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems